Stock comparison
Inspire Medical Systems
INSP$1.7BHealthcare Market cap, Sector
Sanofi Consumer Healthcare India Limited
SANOFICONR.BO$104.98BHealthcare Market cap, Sector
Overall winner
Sanofi Consumer Healthcare India Limited
INSP 07 SANOFICONR.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
INSP0wins
7winsSANOFICONR.BO
46D
B78
33F
A89
44F
B83
67C
B77
45D
A91
28F
A86
29F
A85
Side-by-side metrics
| Metric | INSP | SANOFICONR.BO |
|---|---|---|
| Market cap | $1.7B | $104.98B Winner |
| P/E (TTM) | Winner: 9.1x | 44.0x |
| EV/EBIT | Winner: 22.0x | 31.7x |
| ROIC (TTM) | 6.24% | 59.15% Winner |
| Gross margin | Winner: 85.78% | 68.13% |
| Net margin | 14.33% | 27.35% Winner |
| Revenue CAGR 5y | Winner: 40.6% | 27.01% |
| EPS CAGR 5y | - | 20.67% |
| Debt / Equity | Winner: 0.0x | 0.1x |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
INSP leads on
- P/E (TTM)9.1xvs 44.0x+79%
- Debt / Equity0.0xvs 0.1x+42%
- Revenue CAGR 5y40.6%vs 27.01%+33%
- EV/EBIT22.0xvs 31.7x+30%
SANOFICONR.BO leads on
- Market cap$104.98Bvs $1.7B+98%
- ROIC (TTM)59.15%vs 6.24%+89%
- Net margin27.35%vs 14.33%+48%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.